| SERBIA |
|
|
| Last
Update |
2007 |
2010-02 |
| Company |
Kedrion |
Octapharma |
| Name of
product |
IG
VENA |
Octagam
5% |
| Available
for Hospital therapy |
Yes |
Yes |
| Available
for Home therapy |
None |
Depends on
legal situation, may be used at home
in general |
| IVIG,
SCIG or IMIG |
IVIG |
IVIG |
| Patient´s
age |
Adults &
Children |
Children and
adults |
| Présentation |
Liquid |
Liquid |
| Concentration
% |
5% |
5% |
| Content
of IgG |
95% |
≥ 95% |
| IgG1 |
24,3 -
37,2 mg |
62,2% ± 2,2 |
| IgG2 |
12,4 -
22,1 mg |
31,1% ± 2,3 |
| IgG3 |
0,9 -
1,5 mg |
6,1% ± 1,6 |
| IgG4 |
0,1 -
0,5 mg |
1,2 % ± 0,2 |
| Content
of IgA |
< 0,05 mg/ml |
≤ 0.2
mg/mL |
| Glucose,
Maltose,… |
Maltose |
Maltose 10% |
| Average
dosage for PID |
0,4 - 0,8 g/kg |
0.4 g/kg b.w. |
| Max.
Speed of infusion |
40 drops/minute |
5 ml/kg/hour |
| Intervals
of infusion for PID |
21-28 days |
every 3 to 4
weeks |
| Preserving |
+2C°<
T <+8C° |
Between 2- 25°C |
| Time for
reconstitution |
Ready for use |
none |
| Packaging* |
1g/
20 ml ; 2,5 g/ 50 ml ; 5 g/ 100 ml ;
10 g/ 200 ml |
1g, 2.5g, 5g,
10g |
| * May be different from country to country |
|
|
|
|